SAPPORO CLINICAL LABORATORIESSAPPORO CLINICAL LABORATORIESSAPPORO CLINICAL LABORATORIES

SAPPORO CLINICAL LABORATORIES

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪3.32 B‬JPY
‪380.16 M‬JPY
‪19.68 B‬JPY
‪731.69 K‬
Beta (1Y)
0.25
Employees (FY)
871
Change (1Y)
−67 −7.14%
Revenue / Employee (1Y)
‪22.60 M‬JPY
Net income / Employee (1Y)
‪436.46 K‬JPY

About SAPPORO CLINICAL LABORATORIES


Headquarters
Sapporo
Founded
1965
ISIN
JP3321100004
FIGI
BBG000FHXZP4
Sapporo Clinical Laboratory Inc. engages in the business of clinical testing services for medical industries. It operates through the following segments: Clinical Testing, Dispensing Pharmacy, Medical Equipment Sales and Maintenance, and Others. The Clinical Testing segment provides contract laboratory tests for medical institutions. The Dispensing Pharmacy segment operates pharmacies that issue and dispense prescription medicines. The Medical Equipment Sales and Maintenance sells and maintains general and advanced medical and laboratory equipment. The Others segment develops, sells, and maintains clinical testing system software. The company was founded on September 22, 1965 and is headquartered in Sapporo, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 9776 is 975 JPY — it hasn't changed in the past 24 hours. Watch SAPPORO CLINICAL LABORATORIES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange SAPPORO CLINICAL LABORATORIES stocks are traded under the ticker 9776.
9776 stock has risen by 0.83% compared to the previous week, the month change is a 0.31% rise, over the last year SAPPORO CLINICAL LABORATORIES has showed a −2.50% decrease.
9776 reached its all-time high on Jul 26, 2018 with the price of 2,624 JPY, and its all-time low was 300 JPY and was reached on Mar 10, 2008. View more price dynamics on 9776 chart.
See other stocks reaching their highest and lowest prices.
9776 stock is 0.00% volatile and has beta coefficient of 0.25. Track SAPPORO CLINICAL LABORATORIES stock price on the chart and check out the list of the most volatile stocks — is SAPPORO CLINICAL LABORATORIES there?
Today SAPPORO CLINICAL LABORATORIES has the market capitalization of ‪3.04 B‬, it has increased by 0.83% over the last week.
Yes, you can track SAPPORO CLINICAL LABORATORIES financials in yearly and quarterly reports right on TradingView.
SAPPORO CLINICAL LABORATORIES is going to release the next earnings report on Feb 7, 2025. Keep track of upcoming events with our Earnings Calendar.
9776 net income for the last quarter is ‪165.89 M‬ JPY, while the quarter before that showed ‪56.52 M‬ JPY of net income which accounts for 193.53% change. Track more SAPPORO CLINICAL LABORATORIES financial stats to get the full picture.
SAPPORO CLINICAL LABORATORIES dividend yield was 2.12% in 2023, and payout ratio reached 20.15%. The year before the numbers were 1.82% and 13.49% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 871.00 employees. See our rating of the largest employees — is SAPPORO CLINICAL LABORATORIES on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SAPPORO CLINICAL LABORATORIES EBITDA is ‪1.13 B‬ JPY, and current EBITDA margin is 5.44%. See more stats in SAPPORO CLINICAL LABORATORIES financial statements.
Like other stocks, 9776 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SAPPORO CLINICAL LABORATORIES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SAPPORO CLINICAL LABORATORIES technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SAPPORO CLINICAL LABORATORIES stock shows the sell signal. See more of SAPPORO CLINICAL LABORATORIES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.